A New Phylogenetic Inference Based on Genetic Attribute Reduction for Morphological Data. [PDF]
Feng J +5 more
europepmc +1 more source
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park +6 more
wiley +1 more source
Novel Ensemble Approach with Incremental Information Level and Improved Evidence Theory for Attribute Reduction. [PDF]
Yu P +6 more
europepmc +1 more source
An Attribute Reduction Method Using Neighborhood Entropy Measures in Neighborhood Rough Sets. [PDF]
Sun L, Zhang X, Xu J, Zhang S.
europepmc +1 more source
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source
Unsupervised attribute reduction based on variable precision weighted neighborhood dependency. [PDF]
Li Y, Zhang B, Mo H, Hu J, Liu Y, Tan X.
europepmc +1 more source
A Neighborhood Rough Sets-Based Attribute Reduction Method Using Lebesgue and Entropy Measures. [PDF]
Sun L, Wang L, Xu J, Zhang S.
europepmc +1 more source
CEACAM1 participation in breast cancer progression
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source
Intelligent cybersecurity management in industrial IoT system using attribute reduction with collaborative deep learning enabled false data injection attack detection approach. [PDF]
Alrashdi I, Duraibi S.
europepmc +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source

